Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774
Reference
- Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cancers Editorial Office. Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774. Cancers 2023, 15, 3668. https://doi.org/10.3390/cancers15143668
Cancers Editorial Office. Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774. Cancers. 2023; 15(14):3668. https://doi.org/10.3390/cancers15143668
Chicago/Turabian StyleCancers Editorial Office. 2023. "Expression of Concern: Barańska, A.; Kanadys, W. Oral Contraceptive Use and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis of Case–Control Studies. Cancers 2022, 14, 4774" Cancers 15, no. 14: 3668. https://doi.org/10.3390/cancers15143668